ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):
Tammuella Chrisentery-Singleton, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael U Callaghan, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris V Quon, Michael Recht
Publication:
Blood
Date:
November 5, 2021
Topics:
Bleeding Events, Inhibitors, Prophylactic Treatment

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.